INK & ROSES announced that it has been retained to launch MyEllevate by Cynosure, an innovative, minimally invasive, long-lasting facial rejuvenation solution to define and enhance the jawline and restore a natural-looking, more youthful appearance.
In this role, INK & ROSES will provide support with MyEllevate brand positioning and messaging, and lead earned consumer and trade media relations to drive brand awareness.
ABOUT MYELLEVATE: MyEllevate offers a minimally invasive approach to define and enhance the jawline. The MyEllevate procedure is performed with the ICLED® Surgical Suture System, the first and only patented light-guided technology for facial cosmetic procedures that utilizes the illuminated Suturod® to accurately place sutures without visible incisions. The procedure takes only one hour to perform and typically has a six-to-seven-day recovery—far less downtime than alternatives such as traditional surgical necklifts and lower facelifts. Originally invented and developed by Dr. Gregory Mueller, MD, FACS Board Certified Plastic Surgeon, MyEllevate was acquired by Cynosure, a global leader in medical aesthetics, in August 2021, expanding the company’s surgical product portfolio.
ABOUT THE AGENCY: INK & ROSES is a full service marketing communications firm specializing in beauty and grooming, consumer health and wellness, parenting, lifestyle and corporate communications.
LinkedIn: INK & ROSES